AI주식인사이트AI Stock Insight
B

씨젠

096530KOSDAQ의료용품 및 기타 의약 관련제품 제조업

58.5 / 100

Reference Date: 2026-04-13

Financial Score22.0 / 40
News Sentiment17.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 7.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Seegene is a molecular diagnostics specialist established in 2000, leveraging DNA/RNA analysis to detect disease causes, with 91% of its revenue from exports globally. The company utilizes its proprietary Syndromic qPCR technology and 19 patents to develop multiplex diagnostic products, and is expanding AI-driven diagnostic reagent development through collaborations with Microsoft and Springer Nature.

Number of Employees

822people

Average Salary

95.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
25.77Industry Average 19.893.0Point

Higher than industry avg (caution)

PBR
1.23Industry Average 1.624.0Point

In line with industry avg

ROE
4.82Industry Average -4.893.5Point

Well below industry avg

Debt Ratio
4.85Industry Average 8.885.0Point

Lower than industry avg (good)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲13.6% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲177.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 1.0% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 4Neutral 0Negative 0Average Sentiment Score 80

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 23,900Won52-week high 35,15052-week low 21,850
1-month return5.0Point

1m +7.42% (rising)

Volume trend3.0Point

Volume flat

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0
  • Neutral자기주식처분결과보고서2026-04-10
  • Neutral주요사항보고서(자기주식처분결정)2026-04-10
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
  • Neutral기업가치제고계획(자율공시)2026-03-27
  • Neutral정기주주총회결과2026-03-27